GB9819685D0
(en)
*
|
1998-09-10 |
1998-11-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US6514525B2
(en)
|
1998-09-10 |
2003-02-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US8231899B2
(en)
*
|
1998-09-10 |
2012-07-31 |
Nycomed Danmark Aps |
Quick release pharmaceutical compositions of drug substances
|
US6387410B1
(en)
|
1998-09-10 |
2002-05-14 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US20090297597A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Gary Liversidge |
Modified Release Ticlopidine Compositions
|
US20080113025A1
(en)
*
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
WO2008079102A1
(fr)
*
|
2005-05-10 |
2008-07-03 |
Elan Corporation, Plc |
Composition de loxoprofène à libération modifiée
|
PT1126826E
(pt)
*
|
1998-11-02 |
2008-11-25 |
Elan Pharma Int Ltd |
Composição de metilfenidato de libertação modificada multiparticulada
|
US6183779B1
(en)
*
|
1999-03-22 |
2001-02-06 |
Pharmascience Inc. |
Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
|
IE990406A1
(en)
*
|
1999-05-20 |
2000-12-27 |
Elan Corp Plc |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
|
UA80667C2
(en)
*
|
1999-09-28 |
2007-10-25 |
Panacea Biotec Ltd |
Controlled release composition comprising nimesulide and process for the preparation thereof
|
GB9923436D0
(en)
*
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
EP1623703B1
(fr)
|
1999-10-29 |
2011-10-05 |
Euro-Celtique S.A. |
Formulations d'hydrocodone à liberation lente
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
EP1239857B1
(fr)
*
|
1999-12-22 |
2006-04-19 |
Pharmacia Corporation |
Compositions a liberation double d'un inhibiteur de cyclo-oxygenase-2
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
EP1268430A1
(fr)
*
|
2000-03-21 |
2003-01-02 |
Astion Development APS |
Complexe chimique comprenant un derive de pyridine carboxy et un antagoniste du recepteur d'histamine h2
|
US20020035107A1
(en)
|
2000-06-20 |
2002-03-21 |
Stefan Henke |
Highly concentrated stable meloxicam solutions
|
EP1252886A1
(fr)
*
|
2001-04-27 |
2002-10-30 |
Universiteit Gent |
Compositions pharmaceutiques en forme de pellet pour libération contrôlée
|
AU2002212200A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Universiteit Gent |
Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
|
HU230686B1
(en)
|
2000-10-30 |
2017-08-28 |
Euro Celtique Sa |
Controlled release hydrocodone compositions
|
DE10108122A1
(de)
*
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
DE60237363D1
(de)
*
|
2001-03-15 |
2010-09-30 |
Soligenix Inc |
Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
|
ES2281527T3
(es)
*
|
2001-05-25 |
2007-10-01 |
Cephalon, Inc. |
Formulaciones farmaceuticas solidas que comprenden modafinilo.
|
DK1411900T4
(da)
|
2001-06-01 |
2014-01-27 |
Pozen Inc |
Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
DE10161077A1
(de)
|
2001-12-12 |
2003-06-18 |
Boehringer Ingelheim Vetmed |
Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
|
US20030161875A1
(en)
*
|
2002-02-27 |
2003-08-28 |
Deepak Murpani |
Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
|
GB0205253D0
(en)
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
WO2003082805A1
(fr)
*
|
2002-03-28 |
2003-10-09 |
Synthon B.V. |
Sels de venlafaxine faiblement solubles dans l'eau
|
US7229644B2
(en)
*
|
2002-05-23 |
2007-06-12 |
Cephalon, Inc. |
Pharmaceutical formulations of modafinil
|
BR0312445A
(pt)
*
|
2002-06-07 |
2005-05-10 |
Ranbaxy Lab Ltd |
Sistemas multiunitários para disponibilização de fármaco de liberação modificada
|
SI21301A
(sl)
*
|
2002-09-11 |
2004-04-30 |
LEK farmacevtska družba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem
|
US20040116532A1
(en)
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
CA2498798A1
(fr)
*
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Formulation opioides a liberation prolongee et procedes d'utilisation connexes
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
US8992980B2
(en)
|
2002-10-25 |
2015-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Water-soluble meloxicam granules
|
CN102166184A
(zh)
*
|
2003-03-21 |
2011-08-31 |
麦克内尔-Ppc股份有限公司 |
非甾体抗炎药物的给药方案
|
US20040186180A1
(en)
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
WO2004112756A1
(fr)
*
|
2003-06-26 |
2004-12-29 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
GB0315012D0
(en)
|
2003-06-27 |
2003-07-30 |
Leuven K U Res & Dev |
Zeotiles
|
US8273371B2
(en)
|
2003-06-27 |
2012-09-25 |
Johan Adriaan Martens |
Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs
|
WO2005004915A2
(fr)
*
|
2003-07-09 |
2005-01-20 |
Boehringer Ingelheim International Gmbh |
Compositions contenant meloxicam
|
MXPA05012637A
(es)
*
|
2003-08-08 |
2006-02-24 |
Biovail Lab Int Srl |
Tableta de liberacion modificada del clorhidrato de bupropion.
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050095299A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Wynn David W. |
Controlled release analgesic suspensions
|
WO2005041934A2
(fr)
*
|
2003-10-31 |
2005-05-12 |
Hexal Ag |
Preparation pharmaceutique contenant des substances actives et presentant un enrobage
|
US7700128B2
(en)
*
|
2003-10-31 |
2010-04-20 |
Takeda Pharmaceutical Company Limited |
Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
SI21638A
(sl)
*
|
2003-11-12 |
2005-06-30 |
LEK farmacevtska družba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem ketoprofena
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
SI21637A
(sl)
*
|
2003-12-23 |
2005-06-30 |
LEK farmacevtska dru�ba d.d. |
Farmacevtska oblika z nadzorovanim sproščanjem
|
EP1568369A1
(fr)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
|
DE102004021281A1
(de)
*
|
2004-04-29 |
2005-11-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
|
DE102004030409A1
(de)
*
|
2004-06-23 |
2006-01-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Neue Verwendung von Meloxicam in der Veterinärmedizin
|
EA200971133A1
(ru)
*
|
2004-06-29 |
2010-10-29 |
Никомед Данмарк Апс |
Производство фармацевтических композиций с быстрым высвобождением на основе водонерастворимых лекарственных средств и фармацевтические композиции, получаемые способом по изобретению
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
PT1781264E
(pt)
|
2004-08-04 |
2013-10-16 |
Evonik Corp |
Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
CA2590802A1
(fr)
*
|
2004-12-20 |
2006-06-29 |
Collegium Pharmaceutical, Inc. |
Compositions pharmaceutiques destinees a des troubles du sommeil
|
GB0501809D0
(en)
*
|
2005-01-28 |
2005-03-09 |
Pharmakodex Ltd |
Anti-migraine formulations
|
JP2009514989A
(ja)
*
|
2005-05-10 |
2009-04-09 |
エラン コーポレーション ピーエルシー |
改変放出ロキソプロフェン組成物
|
EP1888045B1
(fr)
*
|
2005-05-24 |
2010-09-08 |
Flamel Technologies |
Composition pharmaceutique pour le traitement de maladies transmises par cox-2
|
UA89684C2
(ru)
|
2005-07-20 |
2010-02-25 |
Панасеа Биотек Лтд. |
Двухслойная фармацевтическая дозированная форма с модифицированным высвобождением нимесулида
|
CN100346778C
(zh)
*
|
2005-07-22 |
2007-11-07 |
海南康力元药业有限公司 |
尼美舒利缓释组合物
|
BRPI0617208A2
(pt)
*
|
2005-09-30 |
2011-07-19 |
Boehringer Ingelheim Vetmed |
preparação farmacêutica contendo meloxicam
|
KR100831771B1
(ko)
*
|
2005-10-27 |
2008-05-27 |
주식회사종근당 |
서방출과 pH 의존성 속방출을 나타내는 약제학적 조성물
|
US20070141151A1
(en)
*
|
2005-12-20 |
2007-06-21 |
Silver David I |
Lansoprazole orally disintegrating tablets
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1965774A2
(fr)
*
|
2005-12-30 |
2008-09-10 |
Cogentus Pharmaceuticals, Inc. |
Formulations pharmaceutiques à usage oral contenant des médicaments anti-inflammatoires non stéroïdiens et des inhibiteurs d'acides
|
WO2007078895A2
(fr)
*
|
2005-12-30 |
2007-07-12 |
Biovail Laboratories International S.R.L. |
Formulations de tramadol à libération modifiée et leurs utilisations
|
US8202535B2
(en)
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8535714B2
(en)
*
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
WO2007099433A2
(fr)
*
|
2006-02-28 |
2007-09-07 |
Wockhardt Ltd |
Forme posologique a liberation controlee de pantoprazole ou d'un de ses sels
|
EP1993518A4
(fr)
*
|
2006-03-06 |
2012-12-12 |
Pozen Inc |
Formes pharmaceutiques pour l'administration d'associations de medicaments
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
US9561188B2
(en)
|
2006-04-03 |
2017-02-07 |
Intellipharmaceutics Corporation |
Controlled release delivery device comprising an organosol coat
|
JP5844028B2
(ja)
|
2006-04-04 |
2016-01-13 |
ケージー アクキュイシチオン エルエルシー |
抗血小板薬及び酸阻害薬を含む経口剤形
|
KR20090007608A
(ko)
*
|
2006-04-24 |
2009-01-19 |
파나세아 바이오테크 리미티드 |
니메술리드를 포함하는 새로운 형태의 저복용 약학조성물 및 이의 조제 및 사용방법
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
JP5230613B2
(ja)
|
2006-05-23 |
2013-07-10 |
テラコス・インコーポレイテッド |
グルコース輸送体阻害剤およびその使用方法
|
US20070281927A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Shanthakumar Tyavanagimatt |
Anti-inflammatory and analgesic compositions and related methods
|
BRPI0602179A
(pt)
*
|
2006-06-08 |
2008-01-22 |
Biolab Sanus Farmaceutica Ltda |
composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|
US8748419B2
(en)
|
2006-06-16 |
2014-06-10 |
Theracos, Inc. |
Treating obesity with muscarinic receptor M1 antagonists
|
KR100812538B1
(ko)
*
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
US8394415B2
(en)
*
|
2006-11-21 |
2013-03-12 |
Mcneil-Ppc, Inc |
Modified release analgesic suspensions
|
CN104803957A
(zh)
|
2007-04-02 |
2015-07-29 |
泰拉科斯有限公司 |
苄基化糖苷衍生物及其用法
|
US20090012165A1
(en)
*
|
2007-07-03 |
2009-01-08 |
Sucampo Ag |
Pharmaceutical combination of nsaid and prostaglandin compound
|
DK2604257T3
(en)
*
|
2007-08-07 |
2017-08-28 |
Acelrx Pharmaceuticals Inc |
ORAL TRANSMUCOSAL DOSAGE FORMS INCLUDING SUFENTANIL AND TRIAZOLAM
|
SG188800A1
(en)
|
2007-08-23 |
2013-04-30 |
Theracos Inc |
Benzylbenzene derivatives and methods of use
|
EP2307022A4
(fr)
*
|
2007-10-31 |
2011-08-24 |
Equitech Corp |
Formulations anti-inflammatoires non stéroïdiennes améliorées (ains)
|
WO2009085952A1
(fr)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Procédé pour préparer des microparticules ayant un faible volume de solvant résiduel
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
US8377453B2
(en)
*
|
2008-03-11 |
2013-02-19 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
WO2009118764A1
(fr)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Composition pharmaceutique comprenant du diclofénac et du paracétamol
|
US9061060B2
(en)
|
2008-07-15 |
2015-06-23 |
Theracos Inc. |
Deuterated benzylbenzene derivatives and methods of use
|
WO2010022313A2
(fr)
|
2008-08-22 |
2010-02-25 |
Theracos, Inc. |
Procédés de préparation d'inhibiteurs de sglt2
|
JP2012502015A
(ja)
|
2008-09-09 |
2012-01-26 |
アストラゼネカ・アクチエボラーグ |
必要がある患者に医薬組成物を送達するための方法
|
US8945592B2
(en)
*
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
EP2379561B1
(fr)
|
2008-11-25 |
2015-11-04 |
University Of Rochester |
Inhibiteurs de mlk et procédés d'utilisation
|
DK3045043T3
(da)
|
2009-02-26 |
2020-08-03 |
Relmada Therapeutics Inc |
Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
|
NZ597534A
(en)
*
|
2009-06-25 |
2013-09-27 |
Pozen Inc |
Method for treating a patient in need of aspirin therapy
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
RU2012115120A
(ru)
*
|
2009-09-17 |
2013-10-27 |
Евоник Дегусса Корпорейшн |
Имплантируемые устройства, которые отличаются профилем высвобождения, и способы их изготовления и применения
|
CA2777366C
(fr)
|
2009-10-12 |
2023-11-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Recipients pour compositions comprenant du meloxicam
|
US20110091544A1
(en)
*
|
2009-10-16 |
2011-04-21 |
Acelrx Pharmaceuticals, Inc. |
Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
TR200908308A1
(tr)
|
2010-01-18 |
2011-08-22 |
Turgut İlaçlari A.Ş. |
Etodolak içeren sürekli salım tablet formulasyonu
|
AU2010347598B2
(en)
|
2010-03-03 |
2014-11-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
US9795568B2
(en)
|
2010-05-05 |
2017-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Low concentration meloxicam tablets
|
CN103153994B
(zh)
|
2010-05-24 |
2016-02-10 |
罗切斯特大学 |
双环杂芳基激酶抑制剂及使用方法
|
EP2394641A1
(fr)
|
2010-05-30 |
2011-12-14 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Formulation pharmaceutique de lornoxicam
|
WO2011153712A1
(fr)
|
2010-06-12 |
2011-12-15 |
Theracos, Inc. |
Forme cristalline d'inhibiteur de sglt2 de type benzyl-benzène
|
JP6133790B2
(ja)
|
2011-02-18 |
2017-05-24 |
ザ スクリプス リサーチ インスティテュート |
ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化
|
KR101310099B1
(ko)
|
2011-04-13 |
2013-09-23 |
안국약품 주식회사 |
아세클로페낙 함유 방출제어형 정제
|
PL2704698T3
(pl)
|
2011-05-05 |
2020-01-31 |
Hennig Arzneimittel Gmbh&Co. Kg |
Postać leku do kontrolowanego uwalniania substancji czynnych
|
DE102011075354A1
(de)
*
|
2011-05-05 |
2012-11-08 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur gezielten Freigabe von Wirkstoffen
|
BR112013028668A2
(pt)
*
|
2011-05-06 |
2017-01-24 |
Glaxosmithkline Llc |
formulações de paracetamol de liberação sustentada
|
US8658631B1
(en)
|
2011-05-17 |
2014-02-25 |
Mallinckrodt Llc |
Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US8524664B2
(en)
|
2011-06-02 |
2013-09-03 |
Colorado Seminary, Which owns and Operates The Univeristy of Denver |
Methods of treating overproduction of cortisol using ACTH antagonist peptides
|
ES2394888B1
(es)
*
|
2011-06-15 |
2013-09-23 |
Farmalider, S.A. |
Forma farmacéutica de liberación modificada de dexketoprofeno e inhibidor de la bomba de protones y uso de la misma.
|
MX2014007935A
(es)
|
2011-12-28 |
2014-11-14 |
Pozen Inc |
Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.
|
CN107569690A
(zh)
*
|
2012-01-04 |
2018-01-12 |
韦尔斯利医药有限公司 |
用于缓解尿频的延长释放制剂及其使用方法
|
CN102600108A
(zh)
*
|
2012-01-17 |
2012-07-25 |
广州科的信医药技术有限公司 |
一种氟比洛芬缓释胶囊及其制备方法
|
CN104884059B
(zh)
|
2012-11-30 |
2018-08-10 |
罗切斯特大学 |
用于hiv/aids治疗的混合谱系激酶抑制剂
|
CN103877085B
(zh)
*
|
2013-10-16 |
2016-05-04 |
山西兰花药业有限公司 |
酮洛芬奥美拉唑缓释微丸及其制备方法
|
WO2015096668A1
(fr)
|
2013-12-23 |
2015-07-02 |
闻晓光 |
Comprimé à deux couches et son procédé de préparation
|
CN105777624A
(zh)
*
|
2014-12-26 |
2016-07-20 |
辽宁药联制药有限公司 |
一种微粉化吗尼氟酯及其组合物
|
EP3288556A4
(fr)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Compositions à désintégration par voie orale
|
WO2017100559A1
(fr)
*
|
2015-12-10 |
2017-06-15 |
Cogwellin Llc |
Formulations à libération contrôlée d'agents actifs libérant du salicylate
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
EP3764983B1
(fr)
|
2018-04-13 |
2021-09-01 |
Santa Farma Ilaç Sanayi A.S. |
Formulation à libération prolongée comprenant de l'acémétacine à libération in vitro bimodale
|
CN109111469A
(zh)
*
|
2018-10-09 |
2019-01-01 |
中国药科大学 |
一种含氯诺昔康的共无定形复合物
|